Qun Y. Zhou

Holistic Medicine
1202 Annapolis Rd Ste E
Odenton, MD 21113

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications

Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy.

Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 17, 2025

Turncoat antibodies unmasked in a model of autoimmune demyelination: from biology to therapy.

Turncoat antibodies unmasked in a model of autoimmune demyelination: from biology to therapy.

Journal: bioRxiv : the preprint server for biology
Published: December 16, 2024

Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan.

Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan.

Journal: mAbs
Published: October 22, 2024

Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins.

Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins.

Journal: Molecules (Basel, Switzerland)
Published: December 12, 2022

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis.

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis.

Journal: Cells
Published: September 11, 2022

Retraction Notice to: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer.

Retraction Notice to: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 07, 2022

A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function.

A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function.

Journal: Cancers
Published: July 06, 2022

Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues.

Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 02, 2021

Engineered Fc-glycosylation switch to eliminate antibody effector function.

Engineered Fc-glycosylation switch to eliminate antibody effector function.

Journal: mAbs
Published: September 07, 2020

Single-Cell RNA-seq Reveals Obesity-Induced Alterations in the Brca1-Mutated Mammary Gland Microenvironment.

Single-Cell RNA-seq Reveals Obesity-Induced Alterations in the Brca1-Mutated Mammary Gland Microenvironment.

Journal: Cancers
Published: June 12, 2020

Inhibition of LIPG phospholipase activity suppresses tumor formation of human basal-like triple-negative breast cancer.

Inhibition of LIPG phospholipase activity suppresses tumor formation of human basal-like triple-negative breast cancer.

Journal: Scientific reports
Published: January 31, 2020

The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins.

The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins.

Journal: Journal of pharmaceutical sciences
Published: September 12, 2018
Showing 1-12 of 67

Last Updated: 09/26/2026